IGF1R and hepatocellular carcinoma: These data strongly support a positive correlation among nuclear YAP expression, IGF-1R, and EMT markers in HCC patients, and suggest a potential role for a YAP–IGF-1R signaling loop in the sorafenib resistance of HCC.